A detailed history of Antipodes Partners LTD transactions in Si Bone, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 2,394 shares of SIBN stock, worth $45,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,394
Holding current value
$45,629
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025

BUY
$13.72 - $18.44 $32,845 - $44,145
2,394 New
2,394 $33,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $654M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.